14M166: Abstracts: SLE – Etiology and Pathogenesis (2264–2267)

Abstract Moderator(s)

• VP

  Virginia Pascual, MD

  Weill Cornell Medical College
  New York, NY, United States

  Disclosure(s): astra zeneca: Consultant (Ongoing), Grant/Research Support (Ongoing); sanofi: Grant/Research Support (Ongoing)
• 

  Trine Jorgensen, PhD

  Lerner Research Institute, Cleveland Clinic Foundation
  Cleveland, OH, United States

  Disclosure(s): No financial relationships with ineligible companies to disclose

Oral abstract session.

Presentations:

• 5:00 PM – 5:10 PM Eastern Time

  Dysregulated Interferon Gamma Signals Promote Systemic Autoimmunity in STAT1 Gain of Function Syndrome
  

  Presenting Author: Shaun Jackson, MD, PhD – Seattle Children's Research Institute
• 5:10 PM – 5:15 PM Eastern Time

  Q&A
  
• 5:15 PM – 5:25 PM Eastern Time

  Platelet-selectin Prime Lupus Neutrophils to Produce Mitochondrial ROS and Participate in SLE Pathogenesis
  

  Presenting Author: Marc Scherlinger, MD, PhD – Beth Israel Deaconess Medical Center Harvard University
• 5:25 PM – 5:30 PM Eastern Time

  Q&A
  
• 5:30 PM – 5:40 PM Eastern Time

  Autoimmune RNA Dysregulation and Seizures: Therapeutic Prospects in Neuropsychiatric Systemic Lupus Erythematosus
  

  Presenting Author: Henri Tiedge, PhD – SUNY Downstate Health Sciences University
• 5:40 PM – 5:45 PM Eastern Time

  Q&A
  
• 5:45 PM – 5:55 PM Eastern Time

  Plasmacytoid Dendritic Cells Are Not Major Producers of Type 1 Interferons in Cutaneous Lupus
  

  Presenting Author: Thomas Vazquez, MD – University of Pennsylvania
• 5:55 PM – 6:00 PM Eastern Time

  Q&A